Last reviewed · How we verify

NCT05464277: INACHOS

Intermediate Normal Versus High Normal Oxygen Levels in the Emergency Department for Severe Traumatic Brain Injury

Terminated NA Last updated 16 July 2024
What this trial tests

NA trial testing Oxygen in Traumatic Brain Injury in 1 participant. Terminated before completion.

Timeline
2 December 2022
Primary endpoint
14 July 2024
14 July 2024

Quick facts

Lead sponsorEvangelismos Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment1
Start date2 December 2022
Primary completion14 July 2024
Estimated completion14 July 2024
Sites2 locations across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Evangelismos Hospital

Who can join

18 and older, any sex, with Traumatic Brain Injury or Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite almost universal usage of supplemental oxygen therapy in patients presenting in the emergency department with traumatic brain injury (TBI), optimal oxygen levels are unclear. The investigators propose a pilot multi-center randomized controlled trial to test the hypothesis that maintaining intermediate normal as opposed to high normal oxygen levels in patients presenting in the emergency department with TBI is feasible, and to obtain preliminary data on the efficacy of the two approaches to oxygen therapy. The aim is that the investigators produce pilot data, which could inform the design of potential subsequent larger clinical trials.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Oxygen

Trials testing the same drug.

Other recruiting trials for Traumatic Brain Injury

Currently open trials in the same condition.

Other Evangelismos Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05464277.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing